3[1]Hildebrant B,Wust P,Ahlers O,et al.The cellular and molecular basis of hyperthermia [J].Crit Rev Oncol Hematol,2002,43(1):33-56.
4[2]Urano M,Ling CC.Thermal enhancement of melphalan and oxaliplatin cytotoxicity in vitro [J].Int J Hyperthermia,2002,18(4):307-315.
5[3]Takemoto M,Kuroda M,Urano M,et al.The effect of various chemotherapeutic agents given with mild hyperthermia on different types of tumours[J].Int J Hyperthermia,2003,19 (2):193-203.
6[4]Mohamed F,Marchettini P,Stuart OA,et al.Thermal enhancement of new chemotherapeutic agents at moderate hyperthermia [J].Ann Surg Oncol,2003,10(4):463-468.
7[5]Sagowski C,Jaehne M,Kehrl W,et al.Tumor oxygenation under combined whole-body-hyperthemia and polychemotherapy in a case of recurrent carcinoma of the oral cavity[J].Eur Arch Otorhinolaryngol,2002,259(1):27-31.
8[6]Urano M,Ling CC.Thermal enhancement of melphalan and oxaliplatin cytotoxicity in vitro [J].Int J Hyperthermia,2002,18(4):307-315.
9[7]Siddik ZH.Cisplatin:mode of cytotoxic action and molecular basis of resistance [J].Oncogene,2003,22 (47):7265-7279.
10[8]Baguley BC,Wilson WR.Potential Of DMXAA combination therapy for solid tumors [J].Expert Rev Anticancer Ther,2002,2 (5):593-603.
